Trial Profile
A retrospective study evaluating efficacy and safety of FOLFIRI-aflibercept combination in refractory patients to first-line chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2020
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colon cancer; Colorectal cancer; Rectal cancer
- Focus Therapeutic Use
- 16 Oct 2016 New trial record